Inositol hexakisphosphate kinase-1 regulates behavioral responses via GSK3 signaling pathways (Q44273064)

1 December 2017

Inositol hexakisphosphate kinase-1 regulates behavioral responses via GSK3 signaling pathways (English)

1 reference

1 December 2017

5

1 reference

1 December 2017

A Chakraborty

1

1 reference

1 December 2017

C Latapy

series ordinal

2

1 reference

1 December 2017

J Xu

series ordinal

3

1 reference

1 December 2017

S H Snyder

series ordinal

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

26 February 2013

1 reference

1 December 2017

1 reference

1 December 2017

19

1 reference

1 December 2017

3

1 reference

1 December 2017

284-293

1 reference

https://scigraph.springernature.com/pub.10.1038/mp.2013.21

1 December 2017

0 references

cites work

Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

The mechanism by which epidermal growth factor inhibits glycogen synthase kinase 3 in A431 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Neurological functions of the masterswitch protein kinase - gsk-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

The phosphoinositide 3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Effective connectivity of AKT1-mediated dopaminergic working memory networks and pharmacogenetics of anti-dopaminergic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

beta-Arrestin: a protein that regulates beta-adrenergic receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Akt/GSK3 signaling in the action of psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

A beta-arrestin 2 signaling complex mediates lithium action on behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Glycogen synthase kinase-3 is essential for β-arrestin-2 complex formation and lithium-sensitive behaviors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

A molecular mechanism for the effect of lithium on development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Signal transduction by the Wnt family of ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

GSK3: a multifaceted kinase in Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

The Wnt signaling pathway in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

The physiology, signaling, and pharmacology of dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

The versatility and universality of calcium signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Cell signalling by inositol pyrophosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Inositol pyrophosphates as mammalian cell signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Influence of inositol pyrophosphates on cellular energy dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Inositol hexakisphosphate kinase 1 regulates neutrophil function in innate immunity by inhibiting phosphatidylinositol-(3,4,5)-trisphosphate signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Inositol hexakisphosphate kinase-2 acts as an effector of the vertebrate Hedgehog pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Inositol diphosphate signaling regulates telomere length

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Inositol pyrophosphates regulate cell death and telomere length through phosphoinositide 3-kinase-related protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Regulation of a cyclin-CDK-CDK inhibitor complex by inositol pyrophosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Inositol hexakisphosphate kinase-2, a physiologic mediator of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

p53-mediated apoptosis requires inositol hexakisphosphate kinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

HSP90 regulates cell survival via inositol hexakisphosphate kinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Casein kinase-2 mediates cell survival through phosphorylation and degradation of inositol hexakisphosphate kinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Phosphorylation of proteins by inositol pyrophosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Protein pyrophosphorylation by inositol pyrophosphates is a posttranslational event

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

GRAB: a physiologic guanine nucleotide exchange factor for Rab3A, which interacts with inositol hexakisphosphate kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Gene deletion of inositol hexakisphosphate kinase 1 reveals inositol pyrophosphate regulation of insulin secretion, growth, and spermiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Turnover of bis-diphosphoinositol tetrakisphosphate in a smooth muscle cell line is regulated by beta2-adrenergic receptors through a cAMP-mediated, A-kinase-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Taste-dependent sociophobia: when food and company do not mix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

The inhibition of phosphatidylinositol-3-kinase induces neurite retraction and activates GSK3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

GSK-3: tricks of the trade for a multi-tasking kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

The role of GSK3 in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Diphosphoinositol polyphosphates: metabolic messengers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Inositol pyrophosphates: structure, enzymology and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Abnormalities in brain structure and behavior in GSK-3alpha mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Inositol polyphosphate multikinase is a nuclear PI3-kinase with transcriptional regulatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Crosstalk between metabolic and neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Obesity and Alzheimer's disease: a link between body weight and cognitive function in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

The glamour and gloom of glycogen synthase kinase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

What Are the bona fide GSK3 Substrates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.21

Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions.

21 January 2018

1 reference

12 December 2020

Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells

1 reference

12 December 2020

Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans

1 reference

12 December 2020

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

1 reference

12 December 2020

Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances

1 reference

12 December 2020

Molecules, signaling, and schizophrenia

1 reference

12 December 2020

A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression

1 reference

12 December 2020

Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia

1 reference

12 December 2020

The role of GSK-3 in synaptic plasticity.

1 reference

12 December 2020

Identifiers

DOI

10.1038/MP.2013.21

1 reference

Dimensions Publication ID

1 December 2017

0 references

1 reference